 Exacerbation dideoxycytidine-induced neuropathy dideoxyinosine Dideoxycytidine ddC dideoxyinosine ddI nucleoside derivatives antiretroviral activity human immunodeficiency virus HIV agents active investigation potential therapies patients HIV infection addition drugs HIV-infected individuals zidovudine major focus research effort agents toxicities agents peripheral neuropathy patient severe neuropathy administration ddI patient clinical trial ddI rapid development toxicity side effect additive synergistic agents